Guorui Properties Ltd (2329) AI Stock Analysis

• Market Cap: HK$506.66M
• Dividend Yield: N/A
• Average Volume (3M): 2.01M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.58
• Revenue Growth: -0.38%
• EPS Growth: -296.42%
• Country: HK
• Employees: 448
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Development
• EPS (TTM): -0.05
• Shares Outstanding: 4,444,418,000
• 10 Day Avg. Volume: 691,400
• 30 Day Avg. Volume: 2,011,266
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.04
• Price to Sales (P/S): 0.16
• P/FCF Ratio: 0.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: HK$0.13 ▼(-4.29% Downside)

The overall stock score of 41 reflects significant financial challenges, including declining revenues, high leverage, and cash flow issues. Technical analysis provides a neutral outlook, while valuation metrics are weak due to negative earnings and no dividend yield. These factors collectively indicate a high-risk investment with limited upside potential.

Positive Factors

Business model diversification

Guorui’s business spans both residential and commercial development plus property-related operations. This structural diversification reduces reliance on single-project sales cycles and supports multiple revenue vectors (sales, leasing, management), which can stabilize cash flow across market cycles.

Primary revenue generation via development

The company’s core model—recognizing revenue from completed property sales—creates a clear pathway to convert inventory into cash as projects complete. Over the medium term, successful project delivery can restore revenue streams and support balance sheet repair if execution and sales recover.

Listed on HKEX

A Hong Kong listing subjects the company to established disclosure standards and provides access to a regional investor base and capital markets. This structural positioning supports potential refinancing, equity raises, and greater governance visibility over the 2–6 month horizon if financing needs arise.

Negative Factors

Declining revenue trend

A roughly 38% decline in reported revenue indicates meaningful scale deterioration. Persistently falling top-line reduces operating leverage, pressures margins, and limits internal cash generation, making it harder to fund projects or service debt without external capital or asset disposals.

High leverage and shrinking equity

The balance sheet shows substantial leverage and declining shareholders’ equity, increasing financial risk. High debt burdens constrain flexibility, raise refinancing and interest-rate exposure, and amplify downside in a property downturn, limiting the company's ability to invest or absorb shocks.

Weak cash flow generation

Operating and free cash flow have fallen significantly, with negative FCF growth noted. Poor cash conversion threatens liquidity for project completion and debt servicing, increasing reliance on external funding or asset sales and elevating execution and refinancing risk over the medium term.

Guorui Properties Ltd Business Overview & Revenue Model

Company Description

Glory Health Industry Limited, an investment holding company, engages in the development of real estate properties in the People's Republic of China. The company operates through four segments: Property Development, Primary Land Construction and Development Services, Property Investment, and Property Management and Related Services. The Property Development segment develops and sells commercial and residential properties. The Primary Land Construction and Development Services segment provides primary land development services, including services for resettlement, and construction of land infrastructure and ancillary public facilities on land owned by the local governments. The Property Investment segment engages in the rental of investment properties. The Property Management and Related Services segment offers property management and related services. It primarily serves individual purchasers for residential properties, as well as various types of corporations and other business entities for commercial properties. The company was formerly known as Guorui Properties Limited and changed its name to Glory Health Industry Limited in July 2022. Glory Health Industry Limited was founded in 1994 and is headquartered in Beijing, China. Glory Health Industry Limited is a subsidiary of Alltogether Land Company Limited.

How the Company Makes Money

Guorui Properties Ltd generates revenue primarily through the sale of residential and commercial properties, which constitutes its core revenue stream. The company also earns income from leasing and rental services of its developed properties, providing a steady cash flow. Additionally, Guorui Properties engages in property management services, further diversifying its income sources. Strategic partnerships with local governments and other real estate developers enhance its project pipeline and can lead to joint ventures, which may contribute significantly to its earnings. The company also benefits from favorable market conditions, governmental policies supporting real estate development, and its reputation for delivering high-quality projects.

Guorui Properties Ltd Financial Statement Overview

Summary

Guorui Properties Ltd faces significant financial difficulties, including declining revenues, ongoing losses, high leverage, and cash flow challenges. The income statement, balance sheet, and cash flow analysis all indicate financial instability and risks.

Income Statement

The income statement reveals a declining trend in revenue with negative profitability. The gross profit margin has been inconsistent, and the company has been experiencing net losses in recent years. Revenue growth has been negative, and EBIT and EBITDA margins have decreased significantly, highlighting operational challenges.

Balance Sheet

The balance sheet shows a relatively high debt-to-equity ratio, indicating significant leverage, which may pose financial risks. Stockholders’ equity has been decreasing, affecting the equity ratio negatively. The return on equity has been negative due to ongoing net losses, pointing to challenges in generating returns for shareholders.

Cash Flow

Cash flow analysis indicates instability, with a significant decline in free cash flow and operating cash flow over recent periods. The lack of positive free cash flow growth and a negative operating cash flow to net income ratio highlight cash flow management issues, potentially impacting liquidity.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.04B	2.71B	2.51B	3.90B	9.90B	5.77B
Gross Profit	127.66M	555.56M	-50.28M	113.52M	1.25B	980.32M
EBITDA	-59.80M	295.14M	-145.86M	-325.93M	581.55M	1.09B
Net Income	-1.41B	-1.24B	-563.97M	-912.78M	228.33M	98.74M
Balance Sheet
Total Assets	56.83B	57.20B	56.35B	57.39B	61.07B	67.52B
Cash, Cash Equivalents and Short-Term Investments	171.08M	158.10M	152.22M	189.51M	556.87M	1.65B
Total Debt	22.59B	22.79B	22.18B	21.25B	20.95B	23.52B
Total Liabilities	44.63B	44.83B	42.57B	43.01B	45.64B	52.41B
Stockholders Equity	9.70B	9.93B	11.17B	11.73B	12.71B	12.49B
Cash Flow
Free Cash Flow	632.07M	678.26M	452.11M	413.47M	4.07B	4.67B
Operating Cash Flow	630.31M	679.53M	512.92M	606.31M	4.35B	4.94B
Investing Cash Flow	105.81M	146.72M	58.95M	-305.41M	184.15M	-2.78B
Financing Cash Flow	-770.21M	-830.50M	-627.40M	-630.90M	-5.65B	-1.11B

Guorui Properties Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Negative. The current price of 0.14 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.12, and above the 200-day MA of 0.12, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 40.33 is Neutral, neither overbought nor oversold. The STOCH value of 28.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2329.

Guorui Properties Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%
0865	48 Neutral	HK$216.01M	-5.07	-5.13%	―	-76.39%	-1142.86%
3639	44 Neutral	HK$175.71M	-0.06	-35.96%	―	-5.63%	-36.30%
2772	42 Neutral	HK$289.02M	-0.16	-34.31%	―	-63.41%	77.97%
2329	41 Neutral	HK$506.66M	-0.33	-13.99%	―	-0.38%	-296.42%
6158	39 Underperform	HK$131.03M	-0.01	―	―	-70.13%	-16.86%

Guorui Properties Ltd Corporate Events

Glory Health Industry Issues Update on Debt Restructuring and Asset Sales After Auditor Disclaimer

Glory Health Industry Limited has provided a quarterly update on efforts to address the disclaimer of opinion issued by its auditors on the 2024 consolidated financial statements, which stemmed from doubts over the group’s ability to realize assets and meet liabilities in the normal course of business. Since its last update, the group has secured an extension approval from Bank of Tianjin on a RMB1.314 billion loan, but broader debt restructuring talks with financial institutions and other creditors remain ongoing. Several key asset disposal and project transfer initiatives, including the overall transfers of its Shenyang company and Foshan Shengpingli project, the sale of Beijing North Fifth Building, and the disposal of Hainan Yunlong Property, are still in the stage of seeking buyers and negotiating terms, with management indicating that successful completion would ease liquidity pressures and significantly reduce total debt. The group is also continuing applications to relevant government authorities for the return of land tied to its Shenyang and Chongming Island projects, and has pledged to make further announcements as material progress is achieved, underscoring the critical importance of these measures for its financial stability and creditor confidence.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.12 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Secures Waiver for Board Compliance Amid Sector Challenges

Glory Health Industry Limited, a company incorporated in the Cayman Islands, has announced a significant update regarding its board composition and compliance with stock exchange listing rules. Following the resignation of Mr. Yuan Hao as an independent non-executive director, the company faced challenges in appointing a suitable replacement due to concerns about the property sector’s operating conditions in China and misalignment with candidates’ appointment terms. Consequently, the company applied for and was granted a waiver from strict compliance with certain listing rules, allowing more time to appoint Mr. Wang Shiyu as an independent non-executive director. This waiver, subject to change by the stock exchange, highlights the company’s proactive measures to maintain compliance and stabilize its board amid challenging market conditions.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.12 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Appoints New Independent Director

Glory Health Industry Limited has appointed Mr. Wang Shiyu as an independent non-executive director, chairman of the internal control committee, and a member of the audit committee, effective December 1, 2025. Mr. Wang brings extensive experience in investment banking, mergers and acquisitions, and corporate globalization, which is expected to strengthen the company’s governance and strategic direction.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.11 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.

Glory Health Industry Limited Announces Board Composition and Committees

Glory Health Industry Limited has announced the composition of its board of directors and the establishment of four committees to oversee various aspects of its operations. The board comprises both executive and independent non-executive directors, with Zhang Zhangsun serving as the chairman. This announcement highlights the company’s commitment to structured governance and operational oversight, which may enhance its industry positioning and stakeholder confidence.

The most recent analyst rating on (HK:2329) stock is a Hold with a HK$0.11 price target. To see the full list of analyst forecasts on Guorui Properties Ltd stock, see the HK:2329 Stock Forecast page.